• citations in SCIndeks: 0
  • citations in CrossRef:0
  • citations in Google Scholar:[]
  • visits in previous 30 days:21
  • full-text downloads in 30 days:14


article: 3 from 59  
Back back to result list
2020, vol. 54, iss. 4, pp. 143-148
New pharmaceuticals: The importance of serendipity
University of Novi Sad, Faculty of Medicine, Department of Pharmacy
Keywords: drug discovery; drug development; drug repositioning
The key elements of serendipity are luck and contemplation. The discovery process includes the recognition of the finding potential based on knowledge and experience. Serendipitous discoveries are common in biomedical sciences. A significant number of pharmaceuticals is the result of serendipity. Drugs belonging to antimicrobial agents, central nervous system active substances as well as antitumor agents, gained great benefit from serendipity conditions. Besides in the traditional, irrational approach in the drug design, serendipitous discoveries have also played role in modern strategies, such as the drug repositioning and the development of multi-target antitumor agents. Serendipitous drugs discoveries can be classified as laboratory or clinical ones, depending on the drug development stage and the circumstances under which the combination of unforeseen events, the knowledge and skills of the researcher occurred. The discovery of a new drug is impossible without outstanding science as well as the dedication, freedom, and open-mindedness of the researcher to act, think, take a risk, and challenge dogmas.
*** (2019) WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Index. Oslo: Norwegian Institute of Public Health,
Ashburn, T.T., Thor, K.B. (2004) Drug repositioning: Identifying and developing new uses for existing drugs. Nature Reviews Drug Discovery, 3: 673-83
Bai, R.Y., Staedtke, V., Rudin, C.M., Bunz, F., Riggins, G.J. (2015) Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis. Neuro-Oncology, 17: 545-54
Ban, T.A. (2006) The role of serendipity in drug discovery. Drug Discovery and Proof of Concept, 8: 335-44
Braña, M.F., Sánchez-Migallón, A. (2006) Anticancer drug discovery and pharmaceutical chemistry: A history. Clin Transl Oncol, 8: 717-28
Brodie, M.J. (2010) Antiepileptic drug therapy the story so far. Seizure, 19: 650-5
Campanario, J.M. (1996) Using citation classics to study the incidence of serendipity in scientific discovery. Scientometrics, 37: 3-24
Cheung-Ong, K., Giaever, G., Nislow, C. (2013) DNA-damaging agents in cancer chemotherapy: Serendipity and chemical biology. Chemistry & Biology, 20: 648-59
Colman, D.R. (2006) The three princes of Serendip: Notes on a mysterious phenomenon. McGill Journal of Medicine, 9: 161-3
Crump, A., Ōmura, S. (2011) Ivermectin, 'wonder drug' from Japan: The human use perspective. Proc Jpn Acad Ser B Phys Biol Sci, 87: 13-28
de Rond, M. (2014) The structure of serendipity. Culture and Organization, 20: 342-58
Desborough, M.J.R., Keeling, D.M. (2017) The aspirin story: From willow to wonder drug. British Journal of Haematology, 177: 674-83
Duffin, J. (2000) Poisoning the spindle: Serendipity and discovery of the anti-tumor properties of the Vinca alkaloids. Canadian Bulletin of Medical History, 17: 155-92
Fu, R.-.G., Sun, Y., Sheng, W.-.B., Liao, D.-.F. (2017) Designing multi-targeted agents: An emerging anticancer drug discovery paradigm. European Journal of Medicinal Chemistry, 136: 195-211
Geromichalos, G.D., Alifieris, C.E., Geromichalou, E.G., Trafalis, D.T. (2016) Overview on the current status of virtual high-throughput screening and combinatorial chemistry approaches in multi-target anticancer drug discovery; Part I. J BUON, 21: 764-79
Hargrave-Thomas, E., Yu, B., Reynisson, J. (2012) Serendipity in anticancer drug discovery. World Journal of Clinical Oncology, 3: 1-6
Jeste, D.V., Gillin, J.C., Wyatt, R.J. (1979) Serendipity in biological psychiatry: A myth?. Arch Gen Psychiatry, 36: 1173-8
Klajn, I., Šipka, M. (2006) Veliki rečnik stranih reči i izraza. Novi Sad: Prometej, I izd
Klein, D.F. (2008) The loss of serendipity in psychopharmacology. JAMA, 299: 1063-5
Kubinyi, H. (1999) Chance favors the prepared mind: From serendipity to rational drug design. Journal of Receptors and Signal Transduction, 19: 15-39
Langedijk, J., Mantel-Teeuwisse, A.K., Slijkerman, D.S., Schutjens, M.H. (2015) Drug repositioning and repurposing: Terminology and definitions in literature. Drug Discovery Today, 20: 1027-34
Li, H., Xiao, H., Lin, L., et al. (2014) Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: Discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6/GP130 interface. Journal of Medicinal Chemistry, 57: 632-41
López-Muñoz, F., Baumeister, A.A., Hawkins, M.F., Alamo, C. (2012) The role of serendipity in the discovery of the clinical effects of psychotropic drugs: Beyond of the myth. Actas Esp Psiquiatr, 40: 34-42
Malaviya, A.N. (2016) Landmark papers on the discovery of methotrexate for the treatment of rheumatoid arthritis and other systemic inflammatory rheumatic diseases: A fascinating story. International Journal of Rheumatic Diseases, 19: 844-51
Milovanović, D.R., Janković, S.M., Ružić-Zečević, D., Folić, M., Rosić, N., Jovanović, D., Baskić, D., Vojinović, R., Mijailović, Ž., Sazdanović, P. (2020) Lečenje koronavirusne bolesti (COVID-19). Medicinski časopis, vol. 54, br. 1, str. 23-43
Pina, A.S., Hussain, A., Roque, A.C. (2009) An historical overview of drug discovery. Methods Mol Biol, 572: 3-12
Sardana, D., Zhu, C., Zhang, M., Gudivada, R.C., Yang, L., Jegga, A.G. (2011) Drug repositioning for orphan diseases. Briefings in Bioinformatics, 12: 346-56
Sneader, W. (2005) Drugs discovered through serendipitous observations involving humans. in: Sneader W. [ed.] Drug Discovery: A History, Chichester: John Wiley & Sons, 432-7
Sneader, W. (2005) Drugs Discovered through serendipity in the laboratory. in: Sneader W. [ed.] Drug discovery: a history, Chichester: John Wiley & Sons, 438-45
Vargesson, N. (2015) Thalidomide-induced teratogenesis: History and mechanisms. Birth Defects Res C Embryo Today, 105: 140-56
Wardrop, D., Keeling, D. (2008) The story of the discovery of heparin and warfarin. British Journal of Haematology, 141: 757-63
Yella, J.K., Yaddanapudi, S., Wang, Y., Jegga, A.G. (2018) Changing Trends in Computational Drug Repositioning. Pharmaceuticals (Basel), 11: 57
Zaffiri, L., Gardner, J., Toledo-Pereyra, L.H. (2012) History of antibiotics: From salvarsan to cephalosporins. Journal of Investigative Surgery, 25: 67-77
Zins, G.R. (1988) The history of the development of minoxidil. Clinics in Dermatology, 6: 132-47


article language: Serbian
document type: Review Paper
DOI: 10.5937/mckg54-28546
received: 25/09/2020
accepted: 20/12/2020
published in SCIndeks: 29/03/2021

Related records

No related records